Design, Synthesis, and Mechanistic Investigation of Novel 1,3,4-Thiadiazole Derivatives Bearing a Morpholine Moiety Against Xanthomonas oryzae pv Oryzae
Journal of Agricultural and Food Chemistry · 05.08.2026 · 74 (30) · 23282-23293
DOI: 10.1021/acs.jafc.5c17399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 21.07.2026. Verfasst von Mengzhi Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Green Pesticide, Center for R&D of Fine Chemicals of Guizhou University, Guizhou, Guiyang550025, People's Republic of China. Hauptthemen laut MEDLINE: Xanthomonas, Thiadiazoles, Anti-Bacterial Agents, Morpholines. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guizhou Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
Bacterial pathogens inflict substantial crop losses and economic damage, threatening global food security. Although antibacterial agents are available, their application is constrained by drug resistance, environmental hazards, and inadequate sustainability. Development of novel and effective antimicrobial agents has become urgent imperative. A series of morpholine-containing 1,3,4-thiadiazole derivatives were designed and synthesized. Compound H6 exhibited the most potent inhibitory activity against Xanthomonas oryzaepv oryzae (Xoo), with EC50 of 1.21 μg/mL–significantly lower than bismerthiazol (EC50 = 64.71 μg/mL) and thiodiazole-copper (EC50 = 63.94 μg/mL). Mechanistic studies revealed H6 inhibits biofilm and extracellular polysaccharide formation, disrupts membrane integrity, induces ROS accumulation, and promotes lipid peroxidation. Transcriptomic analysis demonstrated significant downregulation of key virulence genes (vgrG, accC, MCP), indicating attenuated pathogenicity. These results underscore H6 as a promising bactericidal agent, demonstrating considerable potential in sustainable management of plant bacterial diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Green Pesticide, Center for R&D of Fine Chemicals of Guizhou University, Guizhou, Guiyang550025, People's Republic of China.
- School of Pharmaceutical Sciences, Guizhou University, Guiyang550025, Guizhou, People's Republic of China.
- Guizhou Industry Polytechnic College, Guiyang550008, Guizhou, People's Republic of China.
ORCID-Profile: Danping Chen, Bingqian Liu, Chenchen Li, Song Bai, Zhenchao Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guizhou Province
- National Key Research and Development Program of China
- Guizhou Provincial Foundation for Excellent Scholars
- Guizhou Provincial Basic Research Program (Natural Science) Youth Guidance Project
Zitieren
APA
Yang, M., Li, C., Zhou, Y., Li, Z., Chen, D., Liu, B., Li, C., Bai, S., & Wang, Z. (2026). Design, Synthesis, and Mechanistic Investigation of Novel 1,3,4-Thiadiazole Derivatives Bearing a Morpholine Moiety Against Xanthomonas oryzae pv Oryzae. Journal of Agricultural and Food Chemistry, 74(30), 23282-23293. https://doi.org/10.1021/acs.jafc.5c17399
Vancouver
Yang M, Li C, Zhou Y, Li Z, Chen D, Liu B, et al. Design, Synthesis, and Mechanistic Investigation of Novel 1,3,4-Thiadiazole Derivatives Bearing a Morpholine Moiety Against Xanthomonas oryzae pv Oryzae. Journal of Agricultural and Food Chemistry. 2026;74(30):23282-23293. doi:10.1021/acs.jafc.5c17399
BibTeX
@article{Yang2026,
author = {Yang, Mengzhi and Li, Chengpeng and Zhou, Yue and Li, Zhurui and Chen, Danping and Liu, Bingqian and Li, Chenchen and Bai, Song and Wang, Zhenchao},
title = {Design, Synthesis, and Mechanistic Investigation of Novel 1,3,4-Thiadiazole Derivatives Bearing a Morpholine Moiety Against Xanthomonas oryzae pv Oryzae},
journal = {Journal of Agricultural and Food Chemistry},
year = {2026},
volume = {74},
number = {30},
pages = {23282--23293},
doi = {10.1021/acs.jafc.5c17399}
}
EUVIMED